{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T12:19:35Z","timestamp":1780575575547,"version":"3.54.1"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T00:00:00Z","timestamp":1742169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T00:00:00Z","timestamp":1742169600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Nephrol"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1007\/s10157-025-02649-0","type":"journal-article","created":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T13:54:01Z","timestamp":1742219641000},"page":"987-994","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Pre-transplant tacrolimus fluctuations predict BK virus infection risk in kidney transplants"],"prefix":"10.1007","volume":"29","author":[{"given":"Hisashi","family":"Sakurai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3750-3811","authenticated-orcid":false,"given":"Teppei","family":"Okamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Yonemaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumiya","family":"Yonemaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoko","family":"Hamaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirotake","family":"Kodama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Fujita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hayato","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuyuki","family":"Mori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Fujita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atushi","family":"Imai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reiichi","family":"Murakami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirofumi","family":"Tomita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shingo","family":"Hatakeyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chikara","family":"Ohyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,17]]},"reference":[{"key":"2649_CR1","doi-asserted-by":"publisher","first-page":"E2234971","DOI":"10.1001\/jamanetworkopen.2022.34971","volume":"5","author":"MC Haller","year":"2022","unstructured":"Haller MC, Strohmaier S, Wallisch C, Kammer M, Geroldinger A, Heinze G, et al. Survival benefit of first single-organ deceased donor kidney transplantation compared with long-term dialysis across ages in transplant-eligible patients with kidney failure. JAMA Netw Open. 2022;5:E2234971.","journal-title":"JAMA Netw Open"},{"key":"2649_CR2","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/j.xkme.2020.06.015","volume":"2","author":"A Cohen-Bucay","year":"2020","unstructured":"Cohen-Bucay A, Ramirez-Andrade SE, Gordon CE, Francis JM, Chitalia VC. Advances in BK virus complications in organ transplantation and beyond. Kidney Med. 2020;2:771\u201386.","journal-title":"Kidney Med"},{"key":"2649_CR3","doi-asserted-by":"publisher","DOI":"10.3390\/v14081616","author":"S Kant","year":"2022","unstructured":"Kant S, Dasgupta A, Bagnasco S, Brennan DC. BK virus nephropathy in kidney transplantation: a state-of-the-art review. Viruses. 2022. https:\/\/doi.org\/10.3390\/v14081616.","journal-title":"Viruses"},{"key":"2649_CR4","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.jcv.2009.12.006","volume":"47","author":"R Boothpur","year":"2010","unstructured":"Boothpur R, Brennan DC. Human polyoma viruses and disease with emphasis on clinical BK and JC. J Clin Virol. 2010;47:306\u201312.","journal-title":"J Clin Virol"},{"key":"2649_CR5","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.jcv.2018.10.002","volume":"109","author":"B Demey","year":"2018","unstructured":"Demey B, Tinez C, Fran\u00e7ois C, Helle F, Choukroun G, Duverlie G, et al. Risk factors for BK virus viremia and nephropathy after kidney transplantation: a systematic review. J Clin Virol. 2018;109:6\u201312.","journal-title":"J Clin Virol"},{"key":"2649_CR6","doi-asserted-by":"publisher","first-page":"3119","DOI":"10.1093\/ndt\/gft298","volume":"28","author":"K Masutani","year":"2013","unstructured":"Masutani K, Ninomiya T, Randhawa P. HLA-A2, HLA-B44 and HLA-DR15 are associated with lower risk of BK viremia. Nephrol Dial Transplant. 2013;28:3119\u201326.","journal-title":"Nephrol Dial Transplant"},{"key":"2649_CR7","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.2215\/CJN.00770112","volume":"7","author":"A Sharif","year":"2012","unstructured":"Sharif A, Alachkar N, Bagnasco S, Geetha D, Gupta G, Womer K, et al. Incidence and outcomes of BK virus allograft nephropathy among ABO- and HLA-incompatible kidney transplant recipients. Clin J Am Soc Nephrol. 2012;7:1320\u20137.","journal-title":"Clin J Am Soc Nephrol"},{"key":"2649_CR8","doi-asserted-by":"publisher","DOI":"10.1111\/ctr.13528","volume":"33","author":"HH Hirsch","year":"2019","unstructured":"Hirsch HH, Randhawa PS. BK polyomavirus in solid organ transplantation-guidelines from the American society of transplantation infectious diseases community of practice. Clin Transplant. 2019;33: e13528.","journal-title":"Clin Transplant"},{"key":"2649_CR9","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.3389\/fphar.2020.01142","volume":"11","author":"T van Gelder","year":"2020","unstructured":"van Gelder T, Meziyerh S, Swen JJ, de Vries APJ, Moes DJAR. The clinical impact of the C0\/D ratio and the CYP3A5 genotype on outcome in tacrolimus treated kidney transplant recipients. Front Pharmacol. 2020;11:1142.","journal-title":"Front Pharmacol"},{"key":"2649_CR10","doi-asserted-by":"publisher","first-page":"e2044","DOI":"10.1002\/rmv.2044","volume":"29","author":"S Chong","year":"2019","unstructured":"Chong S, Antoni M, Macdonald A, Reeves M, Harber M, Magee CN. BK virus: current understanding of pathogenicity and clinical disease in transplantation. Rev Med Virol. 2019;29:e2044.","journal-title":"Rev Med Virol"},{"key":"2649_CR11","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1111\/j.1600-6143.2005.00742.x","volume":"5","author":"DC Brennan","year":"2005","unstructured":"Brennan DC, Agha I, Bohl DL, Schnitzler MA, Hardinger KL, Lockwood M, et al. Incidence of BK with tacrolimus versus cyclosporine and impact of preemptive immunosuppression reduction. Am J Transplant. 2005;5:582\u201394.","journal-title":"Am J Transplant"},{"key":"2649_CR12","doi-asserted-by":"publisher","first-page":"1986","DOI":"10.1038\/s41598-017-02140-1","volume":"7","author":"C-L Shen","year":"2017","unstructured":"Shen C-L, Yang A-H, Lien T-J, Tarng D-C, Yang C-Y. Tacrolimus blood level fluctuation predisposes to coexisting BK virus nephropathy and acute allograft rejection. Sci Rep. 2017;7:1986.","journal-title":"Sci Rep"},{"key":"2649_CR13","doi-asserted-by":"publisher","first-page":"348","DOI":"10.4103\/1319-2442.335446","volume":"32","author":"D Turgut","year":"2021","unstructured":"Turgut D, Sayin B, Soy EA, Topcu D\u0130, Ozdemir BH, Haberal M. Tacrolimus intrapatient variability in BK virus nephropathy and chronic calcineurin toxicity in kidney transplantation. Saudi J Kidney Dis Transpl. 2021;32:348\u201354.","journal-title":"Saudi J Kidney Dis Transpl"},{"key":"2649_CR14","doi-asserted-by":"publisher","first-page":"32273","DOI":"10.1038\/srep32273","volume":"6","author":"G Th\u00f6lking","year":"2016","unstructured":"Th\u00f6lking G, Schmidt C, Koch R, Schuette-Nuetgen K, Pabst D, Wolters H, et al. Influence of tacrolimus metabolism rate on BKV infection after kidney transplantation. Sci Rep. 2016;6:32273.","journal-title":"Sci Rep"},{"key":"2649_CR15","doi-asserted-by":"publisher","DOI":"10.3390\/jcm8101586","author":"G Th\u00f6lking","year":"2019","unstructured":"Th\u00f6lking G, Sch\u00fctte-N\u00fctgen K, Schmitz J, Rovas A, Dahmen M, Bautz J, et al. A low tacrolimus concentration\/dose ratio increases the risk for the development of acute calcineurin inhibitor-induced nephrotoxicity. J Clin Med. 2019. https:\/\/doi.org\/10.3390\/jcm8101586.","journal-title":"J Clin Med"},{"key":"2649_CR16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0111128","volume":"9","author":"G Th\u00f6lking","year":"2014","unstructured":"Th\u00f6lking G, Fortmann C, Koch R, Gerth HU, Pabst D, Pavenst\u00e4dt H, et al. The tacrolimus metabolism rate influences renal function after kidney transplantation. PLoS ONE. 2014;9: e111128.","journal-title":"PLoS ONE"},{"key":"2649_CR17","doi-asserted-by":"publisher","first-page":"88","DOI":"10.3109\/03602532.2016.1151037","volume":"48","author":"T Vanhove","year":"2016","unstructured":"Vanhove T, Annaert P, Kuypers DRJ. Clinical determinants of calcineurin inhibitor disposition: a mechanistic review. Drug Metab Rev. 2016;48:88\u2013112.","journal-title":"Drug Metab Rev"},{"key":"2649_CR18","doi-asserted-by":"publisher","first-page":"242","DOI":"10.2133\/dmpk.DMPK-11-RG-105","volume":"27","author":"K Egashira","year":"2012","unstructured":"Egashira K, Sasaki H, Higuchi S, Ieiri I. Food-drug interaction of tacrolimus with pomelo, ginger, and turmeric juice in rats. Drug Metab Pharmacokinet. 2012;27:242\u20137.","journal-title":"Drug Metab Pharmacokinet"},{"key":"2649_CR19","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1681\/ASN.V131221","volume":"13","author":"JMM Boots","year":"2002","unstructured":"Boots JMM, van Duijnhoven EM, Christiaans MHL, Wolffenbuttel BHR, van Hooff JP. Glucose metabolism in renal transplant recipients on tacrolimus: the effect of steroid withdrawal and tacrolimus trough level reduction. J Am Soc Nephrol. 2002;13:221\u20137.","journal-title":"J Am Soc Nephrol"},{"key":"2649_CR20","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s40262-013-0120-3","volume":"53","author":"DA Hesselink","year":"2014","unstructured":"Hesselink DA, Bouamar R, Elens L, van Schaik RHN, van Gelder T. The role of pharmacogenetics in the disposition of and response to tacrolimus in solid organ transplantation. Clin Pharmacokinet. 2014;53:123\u201339.","journal-title":"Clin Pharmacokinet"},{"key":"2649_CR21","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.2217\/pgs-2016-0136","volume":"17","author":"LM Andrews","year":"2016","unstructured":"Andrews LM, De Winter BC, Van Gelder T, Hesselink DA. Consideration of the ethnic prevalence of genotypes in the clinical use of tacrolimus. Pharmacogenomics. 2016;17:1737\u201340.","journal-title":"Pharmacogenomics"},{"key":"2649_CR22","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.1093\/clinchem\/48.10.1668","volume":"48","author":"RHN van Schaik","year":"2002","unstructured":"van Schaik RHN, van der Heiden IP, van den Anker JN, Lindemans J. CYP3A5 variant allele frequencies in Dutch Caucasians. Clin Chem. 2002;48:1668\u201371.","journal-title":"Clin Chem"}],"container-title":["Clinical and Experimental Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-025-02649-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10157-025-02649-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-025-02649-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T20:02:05Z","timestamp":1751054525000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10157-025-02649-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,17]]},"references-count":22,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["2649"],"URL":"https:\/\/doi.org\/10.1007\/s10157-025-02649-0","relation":{},"ISSN":["1342-1751","1437-7799"],"issn-type":[{"value":"1342-1751","type":"print"},{"value":"1437-7799","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,17]]},"assertion":[{"value":"6 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional committee at Hirosaki University School of Medicine (IRB approval number 2019\u2013099-1) and with the 1964 Helsinki declaration.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Patient data were collected and analyzed to investigate the long-term prognosis. All data used in this study were anonymized and stripped of any personally identifiable information to ensure strict patient confidentiality in accordance with applicable regulations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}